MedTrace Logo

Vitaccess Real MG Registry

NCT06064461 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-07-29

No results posted yet for this study

Summary

Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records.

Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.

Conditions

Sponsors & Collaborators

  • Vitaccess Ltd

    lead INDUSTRY

Principal Investigators

  • Mark JW Larkin, PhD · Vitaccess Ltd

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2034-07-31
Completion
2034-07-31

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06064461 on ClinicalTrials.gov